Aflac Incorporated (NYSE:AFL) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP trimmed its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 82.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,932 shares of the financial services provider's stock after selling 50,701 shares during the quarter. Wellington Management Group LLP's holdings in Aflac were worth $1,131,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of AFL. Vanguard Group Inc. increased its stake in shares of Aflac by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock worth $5,310,640,000 after buying an additional 653,275 shares during the period. Norges Bank purchased a new stake in shares of Aflac during the 4th quarter worth $349,699,000. Charles Schwab Investment Management Inc. grew its stake in shares of Aflac by 1.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider's stock worth $333,768,000 after purchasing an additional 47,119 shares in the last quarter. Amundi increased its holdings in Aflac by 81.1% in the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider's stock valued at $285,181,000 after buying an additional 1,232,683 shares during the last quarter. Finally, Guinness Asset Management LTD lifted its holdings in Aflac by 5.2% during the 4th quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider's stock worth $247,682,000 after buying an additional 118,720 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AFL. Piper Sandler boosted their target price on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. JPMorgan Chase & Co. increased their target price on shares of Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. UBS Group boosted their price target on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. Wells Fargo & Company cut their target price on Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 19th. Finally, BMO Capital Markets assumed coverage on Aflac in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 target price for the company. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Aflac presently has a consensus rating of "Hold" and an average target price of $103.93.

Aflac Stock Performance

Aflac stock traded up $0.01 during trading hours on Friday, reaching $107.35. 2,294,639 shares of the stock were exchanged, compared to its average volume of 2,143,187. Aflac Incorporated has a 52-week low of $80.59 and a 52-week high of $115.50. The stock has a market cap of $58.59 billion, a P/E ratio of 11.18, a P/E/G ratio of 3.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The firm's 50 day moving average is $106.72 and its 200 day moving average is $107.33.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Buying and Selling at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now owns 25,393 shares in the company, valued at $2,733,048.59. This represents a 3.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.